These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8101326)

  • 1. Low-birthweight hypertension via enzyme and receptor imprintings of glucocorticoid.
    Oka K; Hirano T; Homma M
    Lancet; 1993 Jul; 342(8866):303-4. PubMed ID: 8101326
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action.
    Waddell BJ; Benediktsson R; Brown RW; Seckl JR
    Endocrinology; 1998 Apr; 139(4):1517-23. PubMed ID: 9528929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero.
    Bertram C; Trowern AR; Copin N; Jackson AA; Whorwood CB
    Endocrinology; 2001 Jul; 142(7):2841-53. PubMed ID: 11416003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids and fetal programming.
    Seckl JR; Nyirenda MJ; Walker BR; Chapman KE
    Biochem Soc Trans; 1999 Feb; 27(2):74-8. PubMed ID: 10093710
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR; Cleasby M; Nyirenda MJ
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin ii receptor in neonatal sheep.
    Whorwood CB; Firth KM; Budge H; Symonds ME
    Endocrinology; 2001 Jul; 142(7):2854-64. PubMed ID: 11416004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of gene expression in the ovine fetus.
    Yang K
    J Reprod Fertil Suppl; 1992; 45():85-95. PubMed ID: 1338959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?
    Edwards CR; Benediktsson R; Lindsay RS; Seckl JR
    Lancet; 1993 Feb; 341(8841):355-7. PubMed ID: 8094124
    [No Abstract]   [Full Text] [Related]  

  • 9. 11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action.
    Benediktsson R; Edwards CR
    Essays Biochem; 1996; 31():23-36. PubMed ID: 9078455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11 beta-hydroxysteroid dehydrogenase--why is it important for the nephrologist?
    Escher G; Frey BM; Frey FJ
    Nephrol Dial Transplant; 1995; 10(9):1506-9. PubMed ID: 8559452
    [No Abstract]   [Full Text] [Related]  

  • 11. 11beta-Hydroxysteroid dehydrogenase type 2 in the rat corpus luteum: induction of messenger ribonucleic acid expression and bioactivity coincident with luteal regression.
    Waddell BJ; Benediktsson R; Seckl JR
    Endocrinology; 1996 Dec; 137(12):5386-91. PubMed ID: 8940361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [11 beta-Hydroxysteroid dehydrogenase deficiency].
    Ando K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():664-7. PubMed ID: 11028423
    [No Abstract]   [Full Text] [Related]  

  • 13. 11 beta-Hydroxysteroid dehydrogenase: a link between the dysregulation of cortisol metabolism and hypertension.
    Donovan SJ
    Br J Biomed Sci; 1999; 56(3):215-25. PubMed ID: 10824333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of 11beta-hydroxysteroid dehydrogenase, glucocorticoid receptor, and mineralocorticoid receptor genes in rat ovary.
    Tetsuka M; Milne M; Simpson GE; Hillier SG
    Biol Reprod; 1999 Feb; 60(2):330-5. PubMed ID: 9915998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance?
    Whorwood CB; Donovan SJ; Wood PJ; Phillips DI
    J Clin Endocrinol Metab; 2001 May; 86(5):2296-308. PubMed ID: 11344242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Rossi GP; Nussdorfer GG
    J Hypertens; 2000 Jul; 18(7):971-2. PubMed ID: 10930196
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.
    Kotelevtsev Y; Brown RW; Fleming S; Kenyon C; Edwards CR; Seckl JR; Mullins JJ
    J Clin Invest; 1999 Mar; 103(5):683-9. PubMed ID: 10074485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone-suppressible hypertension.
    Stewart PM
    Lancet; 2000 Aug; 356(9231):697-9. PubMed ID: 11085685
    [No Abstract]   [Full Text] [Related]  

  • 20. [The actions of glucocorticoid receptor and 11 beta-hydroxysteroid dehydrogenases in the brain].
    Wan SL; Xu JJ; Sun G
    Sheng Li Ke Xue Jin Zhan; 2001 Apr; 32(2):171-3. PubMed ID: 12545895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.